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Introduction
Microvilli are slender F-actin–containing structures on the api-
cal surface of many epithelial cells. Perhaps the best-studied 
examples are the densely packed microvilli of brush borders on 
intestinal and kidney proximal tubule epithelial cells, where mi-
crovilli are believed to increase the surface area for absorption. 
Less well ordered microvilli, having a somewhat different com-
plement of actin binding proteins, are found on the apical aspect 
of other epithelial cells, such as the placental syncytiotropho-
blast (Bretscher, 1991; Bartles, 2000). In neither case is the reg-
ulation of these structures understood.
One protein common to both types of microvilli is ezrin, a 
member of the ezrin/radixin/moesin (ERM) family of mem-
brane-cytoskeletal linking proteins. Members of this family 
have an  300-residue N-terminal 4.1 ERM (FERM) domain, 
followed by a central  150-residue region predicted to be 
largely α-helical, and terminate in an  100-residue domain 
known as the C-ERMAD (C-terminal ERM association do-
main), as it has the ability to bind the FERM domain of all fam-
ily members (Gary and Bretscher, 1993); an F-actin binding site 
lies in the last  30 residues of the C-ERMAD (Turunen et al., 
1994; Pestonjamasp et al., 1995). ERM proteins are conforma-
tionally regulated, as the F-actin binding site in the C-ERMAD, 
and some sites for association with membrane proteins in the 
FERM domain, are masked in dormant molecules when these 
two domains are associated (Bretscher et al., 2002). Activation 
to release the association and expose these binding sites can 
occur through PIP2 binding and subsequent phosphorylation 
of a C-terminal threonine (567 in ezrin), found on the interface 
between the FERM domain and the C-ERMAD (Hirao et al., 
1996; Matsui et al., 1998; Simons et al., 1998; Gautreau et al., 
2000; Fievet et al., 2004).
The cytoskeletal-membrane linking properties of ERM 
proteins are attributed to their ability to bind F-actin through 
their C-terminal domain and membrane proteins, such as CD44, 
CD43, and ICAM-1-3, through their FERM domain (Tsukita 
et al., 1994; Helander et al., 1996; Hirao et al., 1996; Serrador 
et al., 1997, 1998; Heiska et al., 1998; Yonemura et al., 1998). 
In addition to this direct linkage with transmembrane pro-
teins, the FERM domain binds the related scaffolding proteins 
EBP50 (ERM binding phosphoprotein of 50 kD)/NHERF1 and 
E3KARP/NHERF2, proteins enriched in epithelial microvilli 
(Reczek et al., 1997; Yun et al., 1997). These proteins consist of 
two N-terminal PDZ (postsynaptic density/95-discs large/zona 
occludens-1) domains and a C-terminal region that binds tightly 
to isolated FERM domains (Reczek et al., 1997). The EBP50 
binding site on the FERM domain lies on the same surface oc-
cupied by the last helix of the C-ERMAD in the dormant pro-
tein, thereby providing a physical explanation for its masking 
in dormant ezrin (Reczek and Bretscher, 1998; Finnerty et al., 
2004). EBP50 binds the C-terminal tails of many transmem-
brane proteins, including the CFTR, the β2-adrenergic recep-
tor, and the PDGF receptor to regulate aspects of their function 
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(Hall et al., 1998; Short et al., 1998; Cao et al., 1999; Moyer 
et al., 1999; Maudsley et al., 2000; James et al., 2004; Li et al., 
2005). Previously, we identifi  ed EPI64 (EBP50-PDZ interac-
tor of 64 kD) from extracts of placental microvilli, the richest 
known source of both ezrin and EBP50, as a protein that binds 
the PDZ domains of EBP50 (Reczek and Bretscher, 2001). 
EPI64 is a cytosolic protein of 508 residues containing an N-
terminal Tre-2/Bub2/Cdc16 (TBC) domain and ending in the 
sequence DTYL, which binds preferentially to the fi  rst PDZ 
domain of EBP50 (Reczek and Bretscher, 2001).
The current model based on biochemical interactions (Fig. 
1 A) suggests that microvilli should exhibit a uniform distribution 
of phosphorylated ezrin, EBP50, and EPI64 along their length. 
We used high-resolution fl  uorescence microscopy to assess this 
prediction and found that distinct subdomains exist in microvilli 
whose distribution can be regulated by EPI64. By exploring the 
effects of expressing different domains of EPI64, we found that 
when EPI64 is unable to be linked to ezrin, cells have a reduced 
number of microvilli. We have traced this phenomenon to the 
mislocalization of EPI64’s TBC domain, which we fi  nd binds 
directly to Arf6-GTP.
Results
Microvilli contain subdomains distinguished 
by the localization of ezrin and EPI64
To localize specifi  c proteins in microvilli by immunofl  uores-
cence microscopy, 10–15 confocal sections 0.2 μm apart 
covering just the apical aspect of stained human JEG-3 syncy-
tiotrophoblast cells were collected and merged. When the 
plasma membrane was stained with fl  uorescently tagged WGA 
and ezrin localized with specifi  c antibodies, a high degree of 
colocalization was found. Comparing these with phalloidin 
staining for F-actin, the microvillar rootlet extending into the 
Figure 1.  Ezrin and phospho-ERM localiza-
tion in microvilli. (A) Schematic representation 
of biochemical interactions between ezrin, 
EBP50, EPI64, and F-actin. The asterisk de-
notes the C-terminal T567 phosphorylation site 
in ezrin. (B) JEG-3 cells stained with antibodies 
to ezrin (blue), the plasma membrane with 
ﬂ  uorescently conjugated WGA (green), and 
F-actin with ﬂ  uorescently conjugated phalloidin 
(red). Individual channels of the boxed region 
are enlarged in the right panels. The arrows 
identify regions of ezrin localization with the 
plasma membrane, whereas the arrowheads 
identify the microvillar rootlet. (C) Fitted curves 
to the total dataset localizing ezrin, the plasma 
membrane, and F-actin regions in JEG-3 cell 
microvilli. Distance is measured from the mi-
crovillus tip to its base. (D) JEG-3 cells stained 
for pERM (blue), the plasma membrane (green), 
and F-actin (red); the boxed region is enlarged 
in the bottom panel. Arrows indicate membrane-
bound regions weakly stained for pERM   proteins. 
(E) Fitted curves to the total dataset localizing 
pERM, F-actin, and the plasma membrane 
  regions in JEG-3 cell microvilli (top) or pERM, 
F-actin, and total ezrin (bottom). Unlike ezrin, 
pERM levels are more intense toward the mi-
crovillar tips and drop off before the plasma 
membrane (compare with C). (F) Schematic 
representation of microvilli depicting the localiza-
tion of pERM (blue), F-actin (red), the plasma mem-
brane, and total ezrin (green). Bars, 10 μm.EPI64 REGULATES MICROVILLI • HANONO ET AL. 805
cell body was clearly visible, and this allowed us to determine 
the orientation of microvilli in triple-label studies  (Fig. 1 B). To 
quantitate the degree of colocalization of three markers, the fl  u-
orescent intensity along the length of a minimum of 25 micro-
villi was determined, and the mean was assessed. It should be noted 
that because microvilli vary in length (from  0.75 to 1.25 μm), 
this mean gives a measure of colocalization but does not accurately 
refl  ect sharp transitions seen in individual microvilli (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200604046/DC1). 
As expected, the distribution of ezrin closely follows that of the 
plasma membrane (Fig. 1 C).
When the distribution of T567 phosphorylated ezrin 
(pERM) was compared with the plasma membrane, it was found 
that they were largely overlapping but that the pERM localiza-
tion was slightly more enriched in the distal portion of micro-
villi and reduced toward their base (Fig. 1 D, arrows; and Fig. S1). 
Although this is a subtle effect in the means (Fig. 1 E), it is also 
seen in other cell types, such as intestinal Caco-2 epithelial cells 
and porcine kidney proximal tubule LLC-PK1 cells (not 
depicted). In similar analyses, EBP50 was found to precisely 
colocalize with the plasma membrane–like ezrin (Fig. 2 A).
In contrast to the localizations of ezrin and EBP50 in 
JEG-3 cell microvilli, the localization of EPI64 was more 
variable. Traces of individual microvilli never showed a clear 
colocalization with other markers but, rather, were enriched 
in different regions of individual microvilli (Fig. 2 B and Fig. 
S1). As such, the mean distribution curve shows no specifi  c lo-
calization, though the peak of the curve is near the microvilli 
bases. Remarkably, EPI64 was sometimes enriched in the re-
gion of the microvillus rootlet with no ezrin or plasma mem-
brane colocalization.
Overexpression of EPI64 affects 
microvillar domains
To begin examining how microvillar subdomains arise, we in-
vestigated the effects of overexpressing EPI64 and EBP50. 
Overexpressing EPI64 resulted in the majority of microvilli ex-
hibiting enrichment of EPI64 in a region immediately below ez-
rin and associated with the microvillar rootlet (Fig. 3 A, arrows). 
Moreover, overexpressing EPI64 caused EBP50 to now be 
largely coincident with EPI64 and the distribution of both 
EBP50 and EPI64 to be distinct from that of ezrin (Fig. 3 B). 
Thus, overexpressing EPI64 results in redistribution of EBP50 
and enhances the distinction between microvillar subdomains. 
In contrast to EPI64, overexpressing EBP50 had no discernable 
effect on the distribution of ezrin, pERM, EBP50, or EPI64 in 
JEG-3 cells (unpublished data). We therefore focused our stud-
ies on the role of EPI64.
The TBC domain of EPI64 is a regulator 
of microvilli
To further investigate the role of EPI64, we generated several 
N-terminally tagged mutants (Fig. 4 A). Because the C-terminal 
DTYL sequence of EPI64 binds the PDZ domains of EBP50, 
we made a mutant (EPI64-LA) with an additional C-terminal 
alanine known to abolish this interaction (Reczek and Bretscher, 
2001). Some TBC domains are known to accelerate the cata-
lytic activity of Rab GTPases through a catalytic arginine fi  nger 
motif (Neuwald, 1997; Albert et al., 1999), so we mutated 
this residue, arginine 160 in EPI64, to generate EPI64-R160A. 
Figure 2.  EBP50 and EPI64 localization in microvilli. (A, top) JEG-3 cells 
stained for EBP50 (blue), F-actin (red), and the plasma membrane (green). 
The boxed region is enlarged in the right panel. Arrows identify regions of 
EBP50 localization with the plasma membrane, and arrowheads identify 
the microvillar rootlet. (bottom) Fitted curves to the total dataset localizing 
EBP50, F-actin, and the plasma membrane or ezrin regions in JEG-3 cell 
microvilli. (B, top) JEG-3 cells stained for EPI64 (blue), F-actin (red), and the 
plasma membrane (green). The boxed region is enlarged in the right 
panel. Arrows identify regions of EPI64 localization near microvilli bases; 
instances of more distal staining can also be seen (arrowheads). (bottom) 
Fitted curves to the total dataset localizing EPI64, F-actin, and the plasma 
membrane regions in JEG-3 cell microvilli. Distance is measured from a 
microvillus tip to its base. (C) Schematic representation of microvilli depicting 
the localization of EPI64 (blue), F-actin (red), and the plasma membrane 
and EBP50 (green). The dashed line indicates occasional additional local-
ization for EPI64. Bars, 10 μm.JCB • VOLUME 175 • NUMBER 5 • 2006  806
In addition, we made an N-terminal construct (EPI64-NT) con-
taining the TBC domain and a C-terminal construct (EPI64-CT) 
consisting of the C-terminal 189 residues. The expression of 
these constructs modestly enhanced the level of EPI64 expres-
sion as revealed by Western blotting (Fig. 4 B).
Overexpressing EPI64-LA resulted in the reduction or 
loss of microvilli from JEG-3 cells as seen by ezrin or F-actin 
staining, without noticeably affecting the levels of ezrin, pERM, 
or EBP50 in these cells (Fig. 4 B). Instead of being enriched in 
the apical aspect of cells, like overexpressed wild-type EPI64, 
EPI64-LA was found diffuse in the cytoplasm (Fig. 4 C). To 
quantify the microvillar loss phenotype, at least 200 transfected 
cells were assessed for the presence of microvilli, with 46% of 
the transfected cells lacking or exhibiting greatly reduced num-
bers of microvilli, compared with 25% of untransfected or wild-
type EPI64 overexpressing cells that had reduced numbers of 
microvilli. In addition, a small percentage of EPI64 and EPI64-
LA overexpressing cells contained vacuoles (Fig. 4 D), which 
are discussed in the next section. In contrast to EPI64-LA, 
EPI64-R160A overexpression was similar to overexpressing 
wild-type EPI64.
To investigate the mechanism of microvillar loss by EPI64-
LA, we overexpressed domains of the protein. Overexpressing 
EPI64-CT resulted in a reduction of microvilli and an increase in 
the number of ruffl  ing cells (Fig. 4 D), with the ruffl  es enriched 
in the transfected protein (not depicted). Similar to overexpress-
ing EPI64-LA, overexpressing EPI64-NT, containing the TBC 
domain, resulted in microvillar loss. A similar effect was seen 
in cells expressing a mutant TBC domain, EPI64-NT-R160A 
(Fig. 4 D). To explore whether the loss of microvilli resulted 
from a defect in cell polarity, the localization of the tight junc-
tion marker ZO-1 and the adherens junction marker E-cadherin 
was examined in cells overexpressing EPI64 or EPI64-LA. In 
neither case did cell junctions appear signifi  cantly different be-
tween transfected and nontransfected cells (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200604046/DC1).
The data imply that mislocalizing the TBC domain from 
the apical region results in loss of microvilli. Because perturb-
ing the binding of EBP50 to ezrin should reproduce this effect, 
we explored the consequences of overexpressing EBP50-PDZ1-
PDZ2, which lacks the C-terminal ezrin binding site. Consistent 
with this notion, whereas overexpressing wild-type EBP50 had 
no effect on microvilli, overexpressing EBP50-PDZ1-PDZ2 
resulted in the loss of microvilli (Fig. 5, A and B). Moreover, 
knock down of EBP50 by siRNA treatment for 48 h also 
resulted in the loss of surface microvilli, whereas treatment with 
control siRNA did not (Fig. 5, C and D). Interestingly, the micro-
villi located above the adherens junctions were the most resis-
tant to EBP50 knockdown, perhaps suggesting that the lateral 
border provides a signal for microvillus formation that can nor-
mally be propagated across the apical surface.
Overexpressing EPI64 and EPI64-LA 
can cause the production 
of F-actin–coated vacuoles
Overexpressing the full-length EPI64 constructs caused a 
small percentage of cells to contain intracellular vacuoles often 
decorated by EPI64 and F-actin both in JEG-3 cells but more 
dramatically in HeLa cells (Fig. 6 A). Because similar F-actin–
decorated structures are seen in cells overexpressing dominant-
active Arf6 (Brown et al., 2001), we cotransfected tagged EPI64 
and Arf6 and found that the vacuoles were also enriched in 
Arf6 (Fig. 6 B), suggesting a relationship between Arf6 and 
EPI64. We thus examined cells expressing EPI64 and wild type 
or dominant-active (Q67L) or dominant-negative (T27N) mu-
tants of Arf6. EPI64 colocalized on vacuoles with both Arf6 and 
Figure 3.  Overexpressed EPI64 localizes to the bases of microvilli and 
causes a redistribution of EBP50. (A, top) JEG-3 cells transfected with EPI64 
(containing an N-terminal Xpress tag) and stained for the tag (blue), F-actin 
(red), and ezrin (green). A transfected cell is shown in the middle, sur-
rounded by nontransfected ones. Individual channels and the merge of the 
boxed region are enlarged to the right. Arrows identify regions of EPI64 
localization near microvilli bases, ﬂ  anked by red and green staining on ei-
ther side. (bottom) Fitted curves to the total dataset. The distribution of ezrin 
does not appear affected by the overexpression of EPI64. (B, top) JEG-3 
cells transfected with tagged EPI64 and stained for the tag (blue), anti-ezrin 
(green), and anti-EBP50 (red). The boxed region is enlarged to the right. 
The arrows identify regions of EPI64 localization near microvilli bases, 
which appear purple because of colocalization with EBP50. (bottom) Fitted 
curves to the total dataset. Bars, 10 μm.EPI64 REGULATES MICROVILLI • HANONO ET AL. 807
Arf6 Q67L, but not with Arf6 T27N (Fig. 6 B). An enrichment 
of endogenous EPI64 is seen in the region of vacuoles produced 
by Arf6 Q67L overexpression and on areas of the plasma mem-
brane to which it localizes, suggesting that Arf6 may have the 
ability to recruit EPI64 to these regions (Fig. 6 C).
The TBC domain of EPI64 binds 
active Arf6
It has been found that the TBC domain of TRE17 binds Arf6-
GDP (Martinu et al., 2004). Thus, we explored the possibility 
that Arf6 binds to the TBC domain of EPI64. Cells were trans-
fected with Xpress-tagged EPI64 and HA-tagged Arf6, Arf6 
T27N, or Arf6 Q67L. Immunoprecipitates of EPI64 contained 
a small amount of wild-type Arf6, were enriched in Arf6 Q67L, 
and lacked Arf6 T27N (Fig. 7 A). Immunoprecipitates from 
cells expressing EPI64-LA or -NT recovered both Arf6 and Arf6 
Q67L effi  ciently, whereas Arf6 T27N was absent (Fig. 7 A). 
Notably, there was a consistent increase in the relative amount 
of wild-type Arf6 recovered by these constructs when compared 
with EPI64, indicating that the mutated proteins have increased 
access, or bind more effi  ciently, to Arf6-GTP. In addition, both 
constructs also decorated Arf6 Q67L–induced vacuoles, as is 
seen for EPI64 (unpublished data). In coimmunoprecipitation 
experiments, EPI64-R160A behaved indistinguishably from 
EPI64 (Fig. 7 A), suggesting that the R160A mutation has no 
effect on Arf6 binding.
An in vitro binding assay using purifi  ed recombinant pro-
teins was used to determine whether the interaction between 
EPI64 and Arf6-GTP is direct (Fig. 7 B). Immobilized EPI64 
bound Arf6-GTP with a greater affi  nity than Arf6-GDP, whereas 
no binding was observed to immobilized BSA. Collectively, 
these results indicate that, unlike the TBC domain of TRE17, 
which preferentially binds Arf6-GDP (Martinu et al., 2004), the 
TBC domain of EPI64 specifi  cally binds Arf6-GTP.
To evaluate whether EPI64 might be a GTPase activating 
protein (GAP) for Arf6, we assessed the level of Arf6-GTP in 
Figure 4.  Mislocalization of EPI64 causes a 
loss of microvilli in JEG-3 cells. (A) Schematic 
representation of the EPI64 constructs intro-
duced into cells. The asterisk denotes the puta-
tive catalytic arginine, R160. (B) The constructs 
shown in A were transfected into JEG-3 cells 
and allowed to express for  24 h. 25 μg 
of total lysates were separated by 12% SDS-
PAGE followed by a Western blot. (bottom) 
Levels of ezrin, pERM, and EBP50 in trans-
fected cells. (C) JEG-3 cells were transfected 
with tagged EPI64-LA for 18 h and stained for 
the tag (blue), ezrin (green), and F-actin (red). 
Merged confocal sections of the apical regions 
are shown. Bar, 10 μm. (D) Quantiﬁ  cation of 
cells transfected with tagged EPI64 constructs. 
Cells were stained for the tag, ezrin, and F-actin 
and scored as described in Materials and 
methods. Error bars indicate mean ± SD.JCB • VOLUME 175 • NUMBER 5 • 2006  808
cells by making use of the ability of GST-GGA3 to bind se-
lectively to Arf6-GTP (Dell’Angelica et al., 2000). Cells were 
transfected with HA-tagged Arf6, together with full-length 
EPI64 or mutants, and lysed. Lysates were incubated with 
GST-GGA3 beads, and the amount of bound Arf6-GTP was 
determined. Expression of all constructs containing the TBC 
domain did not reduce the level of Arf6-GTP and, in fact, en-
hanced it, when compared with the vector alone control (Fig. 
7 C), making it unlikely that the TBC domain of EPI64 is a 
GAP for Arf6.
Arf6 regulates the abundance of microvilli
The connection between EPI64 and Arf6 prompted us to ex-
plore the effect of expressing wild-type, dominant-active, or 
dominant-negative Arf6 on microvilli of JEG-3 cells. Overex-
pressing wild-type Arf6 and Arf6 Q67L both led to microvillar 
loss, whereas the dominant-negative Arf6-T27N had no effect 
(Fig. 8 A). Dominant-active Arf6 also greatly enhanced the per-
centage of cells with vacuoles, as reported previously (Brown 
et al., 2001). In cells transfected to express HA-Arf6 yet still con-
taining microvilli, the Arf6 colocalized with ezrin and EPI64 in 
Figure 5.  Uncoupling EBP50 from ezrin results in loss of microvilli. (A) Cells were transfected with either Xpress-tagged EBP50 or EBP50-PDZ1-PDZ2 and 
stained for the tag, ezrin, and F-actin, and scored as described in Materials and methods. (right) Western blot of total cell lysates probed with antibodies 
to the Xpress tag epitope. (B) Cells were transfected to Xpress-tagged EBP50-PDZ1-PDZ2 and stained for the tag, ezrin and F-actin. (C) Cells were trans-
fected with siRNA to EBP50 (siEBP50) or luciferase (siGL2) and either stained for EBP50, ezrin, and actin or collected for Western blot analysis. (left) Results 
of scoring cells for the presence of microvilli; (right) Western blot of total cell lysates probed with antibodies to EBP50 and β-tubulin. Error bars indicate 
mean ± SD. (D) Localization of the indicated proteins in cells treated with siEBP50 (top) and siGL2 (bottom). Bars, 10 μm.EPI64 REGULATES MICROVILLI • HANONO ET AL. 809
the apical microvilli (Fig. 8 B), confi  rming observations of Arf6 
at the apical surface of epithelial cells (Altschuler et al., 1999).
Discussion
We have uncovered two unexpected fi  ndings relating to the or-
ganization of the apical domain of epithelial cells. First, using 
high-resolution light microscopy, we found that the microvilli 
of epithelial cells do not have a uniform composition but, rather, 
have distinguishable subdomains that are infl  uenced by mild 
overexpression of EPI64. Second, we have found that express-
ing an EPI64 construct unable to bind the PDZ domains of 
EBP50 results in a dramatic loss of microvilli. Moreover, knock 
down of EBP50, or expression of an EBP50 construct that binds 
EPI64 but not ezrin, also results in the loss of microvilli. Thus, 
our studies suggest that mislocalization of EPI64 results in loss 
of microvilli. Because a major recognizable feature in EPI64 is 
the presence of a TBC domain that we show binds directly to 
Arf6-GTP, it is likely that Arf6 is also involved, directly or indi-
rectly, in regulating microvilli on cells.
As far as we are aware, all previous studies have suggested 
that microvilli are of uniform cytoskeletal composition along 
Figure 6.  Overexpression of EPI64 or EPI64-LA: role of Arf6. (A) JEG-3 or 
HeLa cells were transfected to Xpress-tagged EPI64. After 24 h, cells were 
stained for the tag (green) and F-actin (red). The vacuoles also sometimes 
stain for ezrin and EBP50 (not depicted). (B) JEG-3 cells were cotransfected 
with Xpress-tagged EPI64 and HA-Arf6, HA-Arf6 Q67L, or HA-Arf6 T27N 
and stained for the Xpress-tagged EPI64 (green), F-actin (blue), and HA-
tagged Arf6 (red). A projection through the cell is shown. EPI64 can still be 
seen in the cell microvilli in cells expressing Arf6 T27N. (C) Endogenous 
EPI64 is enriched in regions expressing HA-Arf6 Q67L. Enrichment can be 
seen on intracellular vacuoles (arrows) and on the plasma membrane 
  (arrowheads). (bottom) Enlargement of the regions indicated by the arrow 
labeled 1 and the arrowhead labeled 2. Bars, 10 μm.
Figure 7.  EPI64 interacts directly with Arf6. (A) EPI64 interacts through its 
TBC domain with Arf6-GTP. Xpress-tagged EPI64 constructs and HA-Arf6 
wild type, HA-Arf6 T27N, or HA-Arf6 Q67L were cotransfected into JEG-3 
cells for 6 h, after which Xpress-EPI64 was immunoprecipitated and immu-
noprecipitates were blotted for the tagged Arf6. Arf6 input is 4% of input to 
immunoprecipitates. A representative example of three independent experi-
ments is shown. (B) Recombinant EPI64 immobilized on Sepharose beads 
binds preferentially to puriﬁ  ed myristoylated Arf6-GTPγS over -GDPβS. No 
binding of Arf6 is seen on control BSA beads. (C) EPI64 is not a GAP for 
Arf6. Wild-type HA-tagged Arf6 was coexpressed in JEG-3 cells with 
Xpress-tagged EPI64 constructs or with an empty vector. Cells were lysed, 
and the amount of HA-Arf6 recovered on GST-GGA3 resin was determined 
by Western blotting. Arf6 input is 2% of lysate used for binding assay. 
A representative example of three independent experiments is shown.JCB • VOLUME 175 • NUMBER 5 • 2006  810
their length. Here, we demonstrate that phospho-T567 ezrin is 
enriched toward the distal ends of microvilli, whereas total ez-
rin seems to be uniformly distributed, colocalizing with the 
plasma membrane marker WGA. Additionally, EPI64 is not 
evenly distributed in microvilli but appears to be enriched to-
ward the middle of some and at the base of others. What could 
account for this uneven distribution? It has been shown that the 
microvilli of cultured cells are not static structures but, rather, 
undergo growth and retraction over a period of minutes (Gorelik 
et al., 2003). The actin fi  laments in microvilli, in which the 
barbed ends are associated with the tip, are presumably tread-
milling, as has been documented in other systems (Tyska and 
Mooseker, 2002; Loomis et al., 2003). For example, ezrin might 
become activated at the microvillus tip, associate with the newly 
assembled fi  laments there, and ride down the microvillus with 
treadmilling actin and become dephosphorylated as it nears the 
base. In this way, its membrane-cytoskeletal linking role might 
be inactivated. The fi  nding that EBP50 colocalizes with ezrin 
along the membrane-associated part of the microvillus, extend-
ing slightly beyond the region of pERM, was also initially sur-
prising because EBP50 is proposed to only bind activated ezrin 
molecules (Reczek and Bretscher, 1998). Perhaps as ezrin be-
comes dephosphorylated it takes time to return to its closed 
form (depending on the rates of dissociation from actin and the 
membrane) and so retains some ability to bind EBP50 
after dephosphorylation.
Analysis of cells overexpressing EPI64 reinforces the idea 
that microvilli have different domains: ezrin is found colocaliz-
ing with the plasma membrane of microvilli, whereas EBP50 
and EPI64 are now enriched on the rootlet  0.25 μm below the 
membrane; how this enrichment might occur remains unknown. 
To investigate how EPI64 alters the distribution of proteins in 
microvilli, we began to study its functional domains. To evalu-
ate the importance of the C-terminal linkage of EPI64 to the 
PDZ domains of EBP50, we examined cells expressing EPI64 
with an additional single alanine residue to abolish binding to 
EBP50. Surprisingly, the transfected cells lost microvilli, indi-
cating that the proper localization of EPI64 is necessary for 
microvillar maintenance. By expressing domains of EPI64, 
we found that expressing any construct mislocalizing the TBC 
domain resulted in microvillar loss.
Sequence comparisons suggest that the TBC domain of 
EPI64 might have RabGAP activity (Reczek and Bretscher, 
2001). However, biochemical studies did not identify any GAP 
activity on several purifi  ed Rab proteins using full-length re-
combinant EPI64 (unpublished data; see the following para-
graph). A clue to the possible role of the TBC domain came 
from two sources. First, we noticed that in 5–10% of cells 
overexpressing EPI64 vacuoles formed, often associated with 
F- actin, highly reminiscent of the vacuoles seen in dominant-active 
Arf6-expressing cells (Brown et al., 2001). Second, it was re-
cently reported that the TBC domain of TRE17 binds to Arf6-
GDP (Martinu et al., 2004). Immunoprecipitation experiments 
and in vitro studies using recombinant proteins revealed that the 
TBC domain of EPI64 also binds Arf6, but with a preference for 
Arf6-GTP over Arf6-GDP. Initially, we wondered if EPI64 was 
a GAP for Arf6. RabGAPs have a conserved arginine residue 
necessary for enhancing the hydrolysis of the γ-phosphate of 
GTP (Albert et al., 1999). Cells expressing EPI64-R160A, a 
construct in which this catalytic arginine was mutated to ala-
nine, showed no reduction in microvilli, and the level of Arf6 
associated with EPI64 was not diminished. Indeed, overexpres-
sion of either EPI64 or EPI64-R160A resulted in an enhanced 
level of Arf6- GTP. Therefore, EPI64 is not a GAP for Arf6 and, 
because EPI64 has a preference for Arf6-GTP, it is not a gua-
nine nucleotide exchange factor for Arf6 either. At present, we 
believe that EPI64 is an effector of Arf6-GTP and that, by bind-
ing Arf6-GTP, it protects it from inactivation by a GAP.
While this manuscript was in the fi  nal stages of review, 
Itoh and Fukuda (2006) reported the important fi  nding that 
EPI64 is a GAP for Rab27A and that this activity is abolished 
by a R160K mutation. Combining their results with ours im-
plies that the TBC domain of EPI64 has two distinct functions: 
as a RabGAP for Rab27A and as a binding domain for Arf6-
GTP that is unaffected by the R160A mutation.
Why does expression of EPI64 defective in binding 
EBP50 result in microvillar loss? Loss of microvilli is also seen 
in cells transfected to express just the PDZ domains of EBP50 
or in cells with EBP50 levels reduced by siRNA treatment, 
thereby breaking the linkage to ezrin. Furthermore, overexpre  ssing 
wild-type Arf6 or its mutant that binds GTP constitutively 
Figure 8.  Arf6 localizes to microvilli, and its overexpression results in loss 
of microvilli. (A) JEG-3 cells transfected to express HA-Arf6 constructs were 
stained for the tag, ezrin, and F-actin. Cells were scored as described in 
Materials and methods. Error bars demonstrate mean ± SD. (B) JEG-3 cells 
transfected with HA-tagged wild-type Arf6 for 6 h and stained for the HA 
tag (red), ezrin (green), and F-actin (blue). (bottom) JEG-3 cells were trans-
fected with HA-Arf6 and Xpress-EPI64 for 6 h and stained for the HA-tag 
(red), Xpress tag (green), and ezrin (blue). Bars, 10 μm.EPI64 REGULATES MICROVILLI • HANONO ET AL. 811
also results in microvillar loss. Because overexpression of the 
dominant-active Arf6 results in the formation of actin-contain-
ing vacuoles in the majority of cells, it is possible that the loss 
of microvilli is simply due to sequestration of F-actin internally. 
However, we do not think this is very likely, as overexpression 
of wild-type Arf6, which induces a very much lower level of 
vacuoles, also results in microvillar loss, including cells where 
no vacuoles are evident. Although these data suggest a correla-
tion between elevated levels of mislocalized Arf6-GTP and the 
loss of microvilli, we also attempted to explore the conse-
quences of Arf6 depletion by siRNA. Although we were able to 
knock down expression of transfected HA-Arf6 about fi  vefold, 
no effect on microvilli was seen in siRNA-treated HA-Arf6 ex-
pressing or otherwise wild-type cells (unpublished data). 
Whether these data suggest that microvilli can exist in the ab-
sence of Arf6 function, which is consistent with the lack of in-
terference by expression of the dominant-negative Arf6-T27N 
mutant, or that Arf6 was not suffi  ciently reduced, remains an 
open question. If Arf6 is directly relevant to the regulation of 
microvilli, an attractive scenario is that Arf6-GDP is returned to 
the plasma membrane through a membrane-recycling pathway, 
where it is acted upon at the plasma membrane by Arf6 guanine 
nucleotide exchange factors such as ARNO or EFA6 (Franco et 
al., 1998, 1999) and then captured by EPI64. Microvillar forma-
tion or maintenance might fi  rst require capture of Arf6-GTP by 
EPI64, followed by Arf6 inactivation, when it is brought in 
close proximity to a microvillar ARF-GAP. Consistent with this 
model, we found that the association of Arf6-GTP with EPI64 
was elevated in mutants defective in microvillar localization. 
Moreover, in a preliminary report, a novel Arf6 GAP (ARF-
GAP) was shown to bind the activated form of ezrin (Wu, F., 
H. Deng, R. Zhou, Z. Guo, Z. Fan, K. Yuan, X. Cao, J. Forte, 
and X. Yao. 2005. American Society for Cell Biology Annual 
Mee ting. Abstr.  1804).
Among the known effectors of Arf6 is phosphatidylinosi-
tol-4 phosphate 5 kinase-α (PI[4]P5Kα), which generates PIP2 
at the plasma membrane (Honda et al., 1999). Excess PI(4)P5Kα, 
by either overexpression of the protein or overexpression of 
dominant-active Arf6, induces the formation of vacuoles rich in 
PIP2 and F-actin (Brown et al., 2001). This appears to be a con-
sequence of greatly enhanced endocytosis and decreased mem-
brane recycling through an actin-dependent mechanism, thereby 
depleting PIP2 from the plasma membrane, ultimately resulting 
in multiple phenotypic consequences (Brown et al., 2001; 
Aikawa and Martin, 2003). The similar phenotype conferred by 
EPI64 overexpression suggests that it drives this system by en-
hancing the level of Arf6-GTP, to hyperactivate PI(4)P5Kα to 
generate excess PIP2. Our results suggest that localized captur-
ing or cycling of EPI64-Arf6-GTP is necessary for the mainte-
nance of microvilli. If this is the case, one possibility is that 
PI(4)P5K has to be locally activated to maintain microvilli. As it 
has been reported that PIP2 binding to ezrin is the fi  rst step in its 
activation (Fievet et al., 2004), one attractive model is that tran-
sient locally elevated levels of PIP2 might be responsible for ini-
tiating or maintaining active ezrin necessary for microvilli.
In summary, we have shown that microvilli have subdo-
mains and uncovered an involvement of EPI64 in regulating the 
presence of microvilli on the cell surface. We have also shown 
that the EPI64’s TBC domain binds Arf6-GTP, which is the sec-
ond example of a TBC domain interacting with Arf6, indicating 
that the function of TBC domains may extend beyond their 
RabGAP activities to encompass other small GTPases involved 
in membrane traffi  cking. A recent report suggested that actin 
organization and clathrin-mediated endocytosis at the apical 
surface of polarized epithelial cells are regulated by Arf6 
 (Hyman  et  al., 2006). The collected data suggest that EPI64 inte-
grates actin cytoskeletal organization and membrane traffi  cking 
events mediated by Arf6 and Rab27A, thereby placing it at a 
pivotal point in balancing these processes. It will be fascinating 
to further unravel the connection between microvillar structure, 
endocytosis, and these proteins; such studies are under way.
Materials and methods
Cell culture
JEG-3 and HeLa cells (American Type Culture Collection) were maintained 
in a 5% CO2 humidiﬁ  ed atmosphere at 37°C in MEM (Invitrogen) with 
10% FBS (Invitrogen).
Antibodies and other reagents
Antisera and afﬁ  nity-puriﬁ  ed antibodies against human ezrin and EBP50 
were described previously (Bretscher, 1989; Reczek et al., 1997). Hexa-
histidine-tagged EPI64 was expressed in insect cells, puriﬁ  ed, and used to 
elicit antibody production in rabbits. The afﬁ  nity-puriﬁ  ed antibody recog-
nized a single band at 64 kD in total extracts of several cultured cells (Fig. 
S2, available at http://www.jcb.org/cgi/content/full/jcb.200604046/
DC1). Speciﬁ   c antibodies for phospho-T567 ezrin/T564 radixin/T558 
moesin were obtained from Cell Signaling Technology or generated 
against the peptide CRDKYK(Tp)LRQIR (Matsui et al., 1998). Antibodies 
against the Xpress epitope were purchased from Invitrogen (anti-Xpress) or 
Santa Cruz Biotechnology, Inc. (OmniProbe M-21). Anti-HA (HA.11) was 
obtained from Covance Research Products. Mouse anti-Arf6 was provided 
by C. D’Souza-Schorey (University of Notre Dame, Notre Dame, Indiana). 
Mouse anti–ZO-1 and anti–E-cadherin were obtained from BD Biosciences. 
The antibody against tubulin (N356) was purchased from GE Healthcare. 
Donkey anti–rabbit Alexa Fluor 488, goat anti–mouse Alexa Fluor 568, 
goat anti–rabbit Rhodamine Red-X, ﬂ   uorescently conjugated phalloidin, 
and WGA were obtained from Invitrogen. Donkey anti–rabbit and anti–
mouse Cy5 were obtained from Jackson ImmunoResearch Laboratories. 
Goat anti–rabbit HRP was obtained from MP Biomedicals. GTPγS and 
GDPβS were obtained from Sigma-Aldrich. The siRNAs targeting human 
EBP50 (5′-C  G  G  C  G  A  A  A  A  C  G  T  G  G  A  G  A  A  G  -3′) and Luciferase GL2 (5′-C  G-
U  A  C  G  C  G  G  A  A  U  A  C  U  U  C  G  A  -3′) were obtained from Dharmacon.
Western blotting and immunoﬂ  uorescence
Protein samples were separated by SDS-PAGE and transferred to Immobi-
lon-P (Millipore). Western blotting was done as described previously 
  (Reczek and Bretscher, 2001). For immunoﬂ  uorescence, cells grown on 
glass coverslips were ﬁ   xed in 3.7% formaldehyde/PBS for 10 min at 
room temperature. Cells were permeabilized in 0.2% Triton X-100/PBS 
for 5 min at room temperature, rinsed in PBS, and incubated with primary 
antibodies in PBS/2% FBS. After washing in PBS, secondary antibodies 
and additional markers (phalloidin and/or WGA) were added in PBS/2% 
FBS (unless WGA was included, in which case, FBS was omitted). Cells 
were mounted on glass slides in Vectashield (Vector Laboratories) and ob-
served on a microscope (Eclipse TE-2000U; Nikon) using a 100× 1.4 NA 
lens (Nikon) on a confocal imaging system (UltraView LCI; PerkinElmer). 
Z-series images of single focal planes were obtained at 0.2-μm steps 
through the cells on a 12-bit digital output charge-coupled device camera 
(C4742-95-12ERG; Hamamatsu). Maximum projections of apical sec-
tions and identical contrast enhancements to all images were performed 
using   ImageJ (NIH).
Measurements of microvillar protein distribution
Fluorescence intensity grayscale levels along the length of at least ﬁ  ve ran-
dom microvilli on each of at least ﬁ  ve different cells were measured by se-
lecting a linear region of interest along the length of each microvillus from JCB • VOLUME 175 • NUMBER 5 • 2006  812
its tip to actin rootlet (or the opposite end of staining if not stained for 
actin) using the UltraView software and recorded in Excel (Microsoft). 
R (http://www.R-project.org) was used to analyze protein distribution 
trends in the microvilli of each dataset. In brief, the mean intensity of the 
dataset was subtracted from each recorded point to center the numbers on 
a common point on the y axis (y = 0). These new numbers were used to 
generate a scatter plot of all data points followed by the application of a 
smooth curve ﬁ  tted by LOESS linear regression.
DNA constructs
Xpress-tagged EPI64 and EPI64-LA constructs in pcDNA 3.1 His/Xpress 
were described previously (Reczek and Bretscher, 2001). Xpress-tagged 
EPI64 constructs expressing the N-terminal (residues 1–324, including the 
TBC domain) or C-terminal halves (residues 319–508) of EPI64 were gen-
erated by PCR. Xpress-tagged EPI64-R160A and EPI64-NT-R160A were 
made by PCR mutagenesis. Xpress-tagged EBP50 constructs were derived 
by subcloning from previously described GST constructs (Reczek and 
Bretscher, 1998) into pcDNA3.1 His/Xpress. HA-tagged Arf6 constructs 
were a gift from J. Donaldson (National Institutes of Health, Bethesda, 
MD; Peters et al., 1995). The construct expressing GST-GGA3VHS-GAT was 
a gift from J. Bonifacino (National Institutes of Health, Bethesda, MD; 
Dell’Angelica et al., 2000).
Cell transfection
Polyethylenimine (PEI) has been shown to be a nontoxic transfection re-
agent (Durocher et al., 2002). JEG-3 cells were seeded in 60-mm dishes to 
be 60–70% conﬂ  uent at the time of transfection. 1 μg of DNA was mixed 
with 50 μl of serum and antibiotic-free MEM and 5 μl of 1 mg/ml PEI 
  Linear (mol wt 25,000; Polysciences, Inc.), previously dissolved in water 
at room temperature for 10 min. Cells were washed with serum and anti-
biotic-free MEM and overlaid with the DNA/MEM/PEI mixture in 2 ml of 
serum and antibiotic-free MEM and incubated under normal growing con-
ditions. After 4 h, 1.6 ml of serum and antibiotic-free medium and 400 μl 
of FBS was added to the cells. Cells were allowed to recover for 24–48 h. 
For 6-h transfections, cells 80–90% conﬂ  uent were washed and incubated 
for 2 h with the DNA/MEM/PEI mixture before the supplementation of 
additional MEM and FBS. Under the conditions used,  50% of the cells 
were transfected.
siRNA transfection
JEG-3 cells were seeded in 60-mm dishes to be 30% conﬂ  uent at the time 
of transfection. Cells were washed twice with PBS before adding 4 ml of 
OptiMEM medium (Invitrogen). 2.5 μl of 20 μM Block-iT Alexa Fluor Red 
Fluorescent Oligo (Invitrogen) and 2.5 μl of 20 μM duplex siRNA target-
ing either EBP50 or Luciferase (GL2) for control were diluted into 500 μl 
OptiMEM. 5 μl of Lipofectamine RNAiMAX (Invitrogen) was diluted into 
500 μl OptiMEM per reaction, mixed with diluted siRNA, and incubated 
at room temperature for 15 min. The resulting 1-ml volume of Lipofectamine 
complexed with siRNA was added to cells and incubated at 37°C. After 4 h, 
the medium was replaced with 4 ml of MEM with 10% FBS and L-glutamine. 
48 h after transfection, cells were either ﬁ  xed and stained for immuno-
ﬂ  uorescence or lysed for Western blot analysis.
Scoring the apical surface phenotype of transfected cells
Transfected JEG-3 cells were stained for ezrin, actin, and the expressed pro-
tein (for identifying transfected cells) to indicate the overall apical mem-
brane phenotype. At least 200 cells were counted for each experiment and 
scored as normal, lacking/few microvilli, or rufﬂ  ing. In instances where cells 
were rufﬂ  ing but still had normal-looking microvilli, cells were scored as ruf-
ﬂ  ing. Where surface structures did not clearly fall into the above categories, 
cells were scored as having abnormal microvilli. The siRNA-treated JEG-3 cells 
containing Alexa Fluor red ﬂ   uorescent oligo (to identify transfected 
cells) and siRNA targeting either EBP50 or GL2 were stained for ezrin. 
150 cells were counted for each experiment and scored as described.
Coimmunoprecipitation of EPI64 and Arf6
After a 6-h transfection in 100-mm dishes, JEG-3 cells were washed in pre-
warmed PBS at 37°C and treated for 2 min at 37°C with 5 ml of freshly 
made 1.25 mM DSP in PBS (Pierce Chemical Co.) to cross-link proteins. 
Cells were then washed in prewarmed TBS (50 mM Tris, pH 7.4, and 
150 mM NaCl) at 37°C and incubated in 10 ml of fresh TBS for an additional 
15 min at 37°C to quench the cross-linking reaction. Each dish was lysed 
in 1 ml of ice-cold RIPA buffer (0.1% SDS, 1% Triton X-100, 1% deoxycho-
late, 150 mM NaCl, 1 mM EDTA, and 25 mM Tris, pH 7.4) with protease 
inhibitors and clariﬁ  ed by centrifugation at 100,000 g in a TLA 100.3 ro-
tor for 10 min. After removal of 100 μl of clariﬁ  ed supernatant, as a total 
lysate fraction, the remainder was added to a 25 μl volume of protein A 
Sepharose (Sigma-Aldrich) and 5 μg of anti-Xpress OmniProbe M-21 and 
incubated at 4°C for 2 h with gentle inversion. Bead-bound proteins were 
washed with ice-cold RIPA buffer and eluted by boiling in 50 μl of 2× SDS 
sample buffer.
In vitro binding assay
Hexahistidine-tagged EPI64 was puriﬁ  ed from insect cells using standard 
methods and coupled to CNBr-activated Sepharose beads at  1 mg/ml as 
described previously (Bretscher, 1983). Puriﬁ   ed myristoylated Arf6 was 
provided by P. Randazzo (National Cancer Institute, Bethesda, MD; Ha 
et al., 2005). Puriﬁ  ed Arf6 was subjected to nucleotide exchange in the pres-
ence of GTPγS or GDPβS as described previously (D’Souza-Schorey et al., 
1997). A molar excess of Arf6-GTP or -GDP was incubated with 25 μl of 
EPI64 or BSA beads for 2 h at 4°C with gentle inversion in binding buffer 
(50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM MgCl2, and 1 mM DTT). The 
bound protein was then washed extensively with ice-cold binding buffer 
and eluted by boiling in 50 μl of 2× SDS sample buffer. The eluted protein 
was separated by 12% SDS-PAGE and analyzed by Western blotting using 
anti-Arf6 antibodies.
Detection of relative levels of Arf6-GTP
A GST-GGA3 binding assay was used to determine the relative levels of Arf6-
GTP (Santy and Casanova, 2001). In brief, the different EPI64 constructs 
were cotransfected with HA-tagged Arf6 into JEG-3 cells grown on 100-mm 
dishes. After 18–24 h, cells were lysed in 1 ml of ice-cold GGA3 buffer 
(50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM MgCl2, 1% wt/vol Triton 
X-100, and protease inhibitors). Lysates were cleared by centrifugation at 
16,000 g for 5 min at 4°C, and the resulting supernatant was applied to 
50 μg of GST-GGA3VHS-GAT previously immobilized on glutathione Sepharose 
for 1 h at 4°C with continuous gentle inversion to bind Arf6-GTP to GGA3. 
The beads were washed in ice-cold GGA3 buffer, and proteins were eluted 
by boiling in sample buffer, followed by SDS-PAGE and Western blotting.
Online supplemental material
Fig. S1 shows sample plots of individual microvillar protein distributions for 
ezrin, pERM, and EPI64 with respect to the actin cytoskeleton and plasma 
membrane. Fig. S2 shows a Western blot of cell lysates demonstrating the 
speciﬁ   city of the EPI64 antiserum compared with those detecting ezrin 
and EBP50. Fig. S3 shows immunoﬂ  uorescent images of JEG-3 cells over-
expressing EPI64 or EPI64-LA counterstained for the cell junction markers 
ZO-1 and E-cadherin. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200604046/DC1.
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